Design Therapeutics, Inc. SEC filings DSGN
Design Therapeutics, Inc. has 268 filings in SEC EDGAR's recent list, going back to Mar 20, 2020. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Other events
|
May 18, 2026 | May 18, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 28, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 30, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 10, 2025 | Sep 9, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2024 | Aug 5, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2024 | Mar 19, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 25, 2023 | Aug 25, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 1, 2023 | May 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2023 | Mar 14, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Material agreement
|
Mar 22, 2022 | Mar 18, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 20, 2021 | Aug 18, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 6, 2021 | Aug 2, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 7, 2021 | Jun 3, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Mar 30, 2021 | Mar 30, 2021 |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DSGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Carlsbad, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1807120
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.